Article
Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
19 Oct 2020
Abstract excerpt
Chronic liver diseases (CLD) represent a worldwide health problem. While CLDs may have diverse etiologies, a common pathogenic denominator is the presence of liver fibrosis. Cirrhosis, the end-stage of CLD, is characterized by extensive fibrosis and is markedly associated with the development of hepatocellular carcinoma. The most important event in hepatic fibrogenesis is the activation of hepatic stellate cells...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
